Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -125,695 | -437,987 | -395,064 | -231,923 | -120,965 |
| Depreciation Amortization | 3,205 | 21,154 | 16,707 | 12,394 | 6,956 |
| Income taxes - deferred | N/A | N/A | N/A | 59 | N/A |
| Accounts payable and accrued liabilities | -4,226 | 4,997 | 2,042 | 7,444 | -1,415 |
| Other Working Capital | -22,683 | -22,447 | -19,603 | 998 | 26,059 |
| Other Operating Activity | 17,013 | 42,502 | 30,013 | 12,693 | 11,249 |
| Operating Cash Flow | $-132,386 | $-391,781 | $-365,905 | $-198,335 | $-78,116 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 12,225 | 314,950 | 227,841 | 187,115 | 128,166 |
| PPE Investments | -390 | -4,579 | -4,121 | -3,841 | -1,348 |
| Investing Cash Flow | $11,835 | $310,371 | $223,720 | $183,274 | $126,818 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 162,523 | 4,146 | 3,105 | 3,004 | 598 |
| Other Financing Activity | 0 | -361 | -359 | -360 | 0 |
| Financing Cash Flow | $162,523 | $3,785 | $2,746 | $2,644 | $598 |
| Beginning Cash Position | 241,070 | 318,695 | 318,695 | 318,695 | 318,695 |
| End Cash Position | 283,042 | 241,070 | 179,256 | 306,278 | 367,995 |
| Net Cash Flow | $41,972 | $-77,625 | $-139,439 | $-12,417 | $49,300 |
| Free Cash Flow | |||||
| Operating Cash Flow | -132,386 | -391,781 | -365,905 | -198,335 | -78,116 |
| Capital Expenditure | -390 | -4,832 | -4,484 | -4,167 | -1,629 |
| Free Cash Flow | -132,776 | -396,613 | -370,389 | -202,502 | -79,745 |